Compugen Ltd. announced that it will receive $20,000,000 in an equity round of funding on November 10, 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
44.01 USD | -0.23% | -2.07% | -14.23% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.23% | 89.25B | |
+32.09% | 693B | |
+29.39% | 584B | |
-1.34% | 372B | |
+20.34% | 332B | |
+7.39% | 294B | |
+14.25% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.49% | 168B |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- Compugen Ltd. announced that it expects to receive $20 million in funding from Bristol-Myers Squibb Company